A Phase 2 Multicenter Randomized Clinical Trial of CNTF for MacTel

NCT01949324 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

67

Enrollment

INDUSTRY

Sponsor class

Conditions

Macular Telangiectasia Type 2

Interventions

BIOLOGICAL: Ciliary neurotrophic factor (CNTF)
PROCEDURE: Sham procedure
DEVICE: NT-501 Implant
PROCEDURE: NT-501 Implant procedure

Sponsor

Neurotech Pharmaceuticals

Collaborators

[object Object]
[object Object]